Forsyth Douglas
- SEC CIK
- 0001240801
In the past year, 1 open-market purchase filing worth $286.6K and no sales.
Current role at each company
- INBX Inhibrx Biosciences, Inc.Directoras of Sep 18, 2026
- Inhibrx, Inc.Directoras of May 30, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $286.6K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$286.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Forsyth Douglas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INBX Inhibrx Biosciences, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 (view filing)4:26 PM ET | Sep 8 | Same day | Forsyth DouglasDirector | PPurchase | +2.50K | $114.65 | +$286.6K | +1.1%227.1K after | |
| Aug 26, 2024 (view filing) | Aug 22-23 | 4 days | Forsyth DouglasDirector | PPurchase | +75.0K | $13.83 | +$1.04M | +50.1%224.6K after | 2 lots |